Nitric oxide synthase

Nitric oxide synthases (NOSs) are a family of enzymes catalyzing the production of nitric oxide (NO) from L-arginine.

Uses your system voice; voice and rate in settings.

≈ 4 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Nitric oxide synthases (NOSs) are a family of enzymes catalyzing the production of nitric oxide (NO) from L-arginine. NO is an important cellular signaling molecule. It helps modulate vascular tone, insulin secretion, airway tone, and peristalsis, and is involved in angiogenesis and neural development.

It may function as a retrograde neurotransmitter. Nitric oxide is mediated in mammals by the calcium-calmodulin controlled isoenzymes eNOS (endothelial NOS) and nNOS (neuronal NOS). The inducible isoform, iNOS, involved in immune response, binds calmodulin at physiologically relevant concentrations, and produces NO as an immune defense mechanism, as NO is a free radical with an unpaired electron.

It is the proximate cause of septic shock and may function in autoimmune disease. In the context of eukaryote biology, nitric oxide synthase refers to nitric-oxide synthase (NADPH) ( ), which catalyzes the reaction: 2 L-arginine + 3 NADPH + 3 H + + 4 O 2 \rightleftharpoons 2 citrulline +2 nitric oxide + 4 H 2 O + 3 NADP + NOS isoforms catalyze other leak and side reactions, such as superoxide production at the expense of NADPH.

As such, this stoichiometry is not generally observed, and reflects the three electrons supplied per NO by NADPH. Eukaryotic NOS isozymes are catalytically self-sufficient. The electron flow is: NADPH → FAD → FMN → heme → O 2 .

Tetrahydrobiopterin provides an additional electron during the catalytic cycle which is replaced during turnover. Zinc, though not a cofactor, also participates but as a structural element.

NOSs are unique in that they use five cofactors and are the only known enzyme that binds flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), heme, tetrahydrobiopterin (BH 4 ) and calmodulin. The EC number 1.14.13.39 specifically refers to synthases with linked oxygenase and reductase domains, i.e. "catalytically self-sufficient" NO synthases.

This kind of synthase is found in eukaryotes and, through independent domain acquisition, Sorangium cellulosum. Most bacteria and archaea have a version that only has an oxidase domain and depend on a partner protein; these are categorized as EC 1.14.14.47 "nitric-oxide synthase (flavodoxin)". All these enzymes' oxygenase domains share a common ancestor (see "oxygenase domain" infobox).

Inhibitors

Ronopterin (VAS-203), also known as 4-amino-tetrahydrobiopterin (4-ABH 4 ), an analogue of BH 4 (a cofactor of NOS), is an NOS inhibitor that is under development as a neuroprotective agent for the treatment of traumatic brain injury.Other NOS inhibitors that have been or are being researched for possible clinical use include cindunistat, A-84643, ONO-1714, L-NOARG, NCX-456, VAS-2381, GW-273629, NXN-462, CKD-712, KD-7040, and guanidinoethyldisulfide, [https://pubchem.ncbi.nlm.nih.gov/compound/2733516 TFPI among others.

The Nobel Prize in Physiology or Medicine 1998 University of Edinburgh, School of Chemistry - NO Synthase Nitric Oxide Synthase in Proteopedia

Text derived from https://en.wikipedia.org/w/index.php?oldid=1369107817 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001369107817 · captured 2026-08-12 · ledger · version history

Cite this page as: encyclopegia.org, “Nitric oxide synthase”, snapshot enwiki-001369107817. https://encyclopegia.org/a/nitric-oxide-synthase

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.